Clinical trials
Phase 1 Lung Neoplasms trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2013 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 6 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Active, not recruiting | 6 |
| Recruiting | 4 |
| Terminated | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Checkpoint Therapeutics, Inc. | 2 |
| Monopar Therapeutics | 2 |
| TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 2 |
| Amgen | 1 |
| BeOne Medicines | 1 |
| Corvus Pharmaceuticals, Inc. | 1 |
| Eli Lilly and Company | 1 |
| IDEAYA Biosciences | 1 |
| Keythera Pharmaceuticals (Australia) Pty Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 26 |
| Carcinoma, Non-Small-Cell Lung | 16 |
| Colorectal Neoplasms | 10 |
| Urinary Bladder Neoplasms | 9 |
| Neoplasm Metastasis | 8 |
| Ovarian Neoplasms | 8 |
| Pancreatic Neoplasms | 8 |
| Stomach Neoplasms | 7 |
| Breast Neoplasms | 6 |
| Neoplasms | 6 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.